Evidence map›Paper›PMID 39287376›Full record

ArticlemSystems2024

Species-level verification of

Cecilie Bucher-Johannessen, Thulasika Senthakumaran, Ekaterina Avershina, Einar Birkeland, Geir Hoff, Vahid Bemanian, Hege Tunsjø, Trine B Rounge

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nutrients · 2026
    Article
  5. Tumor tissue-associatedFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. DietaryFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cecilie Bucher-JohannessenDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Thulasika SenthakumaranDepartment of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway.ORCID 0000-0003-0469-6327
Ekaterina AvershinaDepartment of Tumor Biology, Oslo University Hospital, Oslo, Norway.
Einar BirkelandCenter for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.ORCID 0000-0002-9361-7987
Geir HoffSection for Colorectal Cancer Screening, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Vahid BemanianDepartment of Pathology, Akershus University Hospital, Lørenskog, Norway.
Hege TunsjøDepartment of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway.
Trine B RoungeDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-2677-2722

Funding

Kreftforeningen (NCS) 190179Kreftforeningen (NCS) 198048Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2020056Ministry of Health and Care Services | Helse Sør-Øst RHF (sorost) 2022067Wellcome Trust 202401
6 · The paper itself

Abstract

We have previously demonstrated an association between increased abundance of

Indexed as

Colorectal NeoplasmsRNA, Ribosomal, 16SAdenomaAgedFemaleGastrointestinal MicrobiomeHumansMaleMetagenomeMiddle AgedNorwayRNA, Ribosomal, 16Scolorectal cancermicrobiomePhascolarctobacterium

Identifiers

PMID39287376
PMCPMC11494908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.